✦ LIBER ✦

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

✍ Scribed by Bonner, James A.; Harari, Paul M.; Giralt, Jordi; Azarnia, Nozar; Shin, Dong M.; Cohen, Roger B.; Jones, Christopher U.; Sur, Ranjan; Raben, David; Jassem, Jacek; Ove, Roger; Kies, Merrill S.; Baselga, Jose; Youssoufian, Hagop; Amellal, Nadia; Rowinsky, Eric K.; Ang, K. Kian

Book ID: 125807278
Publisher: Massachusetts Medical Society
Year: 2006
Tongue: English
Weight: 275 KB
Volume: 354
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa053422

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cetuximab plus radiotherapy in elderly p

Cetuximab plus radiotherapy in elderly patients with unresectable locally advanced squamous cell carcinoma of head and neck region

✍ Boudabous, H.; Belhabib, G.; Chouchene, N.; Boussen, H. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 49 KB

Distinct patterns of stomatitis with con

Distinct patterns of stomatitis with concurrent cetuximab and radiotherapy for head and neck squamous cell carcinoma

✍ D.I. Pryor; E. Burmeister; B.H. Burmeister; M.G. Poulsen; S.V. Porceddu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Radiotherapy for basaloid squamous cell

Radiotherapy for basaloid squamous cell carcinoma of the head and neck

✍ Dr. James M. Larner; Dr. Ronald H. Malcolm; Dr. Stacey E. Mills; Dr. Henry F. Fr 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 451 KB 👁 2 views

Basaloid squamous cell carcinoma (BSCC) of the head and neck is a recently described high-grade variant of squamous cell carcinoma. It is a biologically virulent neoplasm with a propensity for nodal, as well as systemic, metastases. Because of the limited number of published reports, we reviewed dat

Feasibility of 6-month maintenance cetux

Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck

✍ C. Matuschek, Prof. Dr. E. Bölke, C. Belka, U. Ganswindt… 📂 Article 📅 2013 🏛 Springer 🌐 German ⚖ 525 KB

Feasibility of 6 Months Maintenance Cetu

Feasibility of 6 Months Maintenance Cetuximab After Adjuvant Concurrent Chemoradiation Plus Cetuximab in Squamous Cell Carcinoma of the Head and Neck

✍ Matuschek, C.; Boelke, E.; Belka, C.; Ganswindt, U.; Henke, M.; Stegmaier, P.; B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Concurrent use of cisplatin or cetuximab

Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas

✍ Levy, Antonin; Blanchard, Pierre; Bellefqih, Sara; Brahimi, Nacéra; Guigay, Joël 📂 Article 📅 2014 🏛 Springer 🌐 German ⚖ 693 KB